Streetbeat News

Earnings

NRIX

Nurix Therapeutics reported better-than-expected Q2 financial results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 12:17 pm

ACAD

AEHR

AIMD

LUNR

NKLA

Aehr Test Systems (NASDAQ:AEHR) shares rose 4.4% in pre-market trading after reporting better-than-expected results for its fourth quarter. The company expects FY24 revenue to be at least $100 million and GAAP net income of at least $28 million. Other notable pre-market movers include Ainos, Inc. (NASDAQ:AIMD), Intuitive Machines, Inc. (NASDAQ:LUNR), Nikola Corporation (NASDAQ:NKLA), and ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD).

Portfolio Pulse from Lisa Levin

July 14, 2023 | 12:16 pm

LESL

Leslie's has issued preliminary Q3 2023 adjusted EPS and sales results that are below estimates, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 12:15 pm

JPM

JPMorgan's CFO has announced that the company expects its net interest income run rate to be substantially lower in the future.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 12:14 pm

T

TELUS has issued FY23 adjusted EPS and revenue guidance below estimates, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 12:13 pm

C

Citigroup has projected its FY23 adjusted revenue to be between $78 billion and $79 billion, excluding the impacts related to divestitures in 2023.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 12:09 pm

JPM

JPMorgan Chase & Co reported Q2 net revenue of $42.4 billion, up 34.1% YoY, beating the consensus of $38.96 billion. Noninterest revenue was $20.5 billion, up 25%, driven by higher CIB Markets noninterest revenue. Net interest income increased by 44% YoY to $21.9 billion. Q2 Consumer & Community Banking revenue increased 37% YoY to $17.23 billion. Assets under management stood at $3.2 trillion (+16% Y/Y), and client assets stood at $4.6 trillion (+20% Y/Y). JPM shares are trading higher by 2.75% at $152.97 premarket.

Portfolio Pulse from Akanksha Bakshi

July 14, 2023 | 12:09 pm

OGI

Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI) reported a 14% YoY decline in Q3 revenue to CA$32.8 million ($25 million), impacted by THC inflation. The company also reported a gross loss of CA$4.7 million and a net loss of CA$213.5 million. However, Organigram expects Q4 fiscal 2023 net revenue to be higher than Q3 and to achieve positive adjusted EBITDA. The company's shares were trading 12.91% lower in Friday's pre-market session.

Portfolio Pulse from Vuk Zdinjak

July 14, 2023 | 12:06 pm

C

Citigroup's Q2 2023 banking revenue has been reported at $1.2B, marking a 44% decrease year-over-year.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 12:05 pm

C

Citigroup's Q2 2023 operating expenses have increased by 6% year-on-year to $13.6 billion.

Portfolio Pulse from Benzinga Newsdesk

July 14, 2023 | 12:04 pm